Delivery Order SPE2DB22D3301-SPE2DB25FX3NC

Award Date 10/10/24
Potential Completion Date 10/11/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ramipril 10 mg capsules. The contract, which has a ceiling value of $2,650.03, is a firm fixed-price delivery order with an ultimate completion date of August 26, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of 500 capsules of the prescription drug Ramipril 10 mg, valued at $1,949.35. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ramipril 10 mg capsules. The $3,896.40 firm fixed price contract has an ultimate completion date of August 22, 2024. As this is a delivery order, it is likely part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 for the supply of a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ramipril 10 mg capsules. The $8,078.21 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,647.77, is for the delivery of 4,558,957,998 units of Ramipril 10 mg capsules, which are a cardiovascular medication. The contract is a Firm Fixed Price Delivery Order that has an ultimate completion date of November 2, 2022. It is not designated with any set-aside requirements, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,387.28 firm fixed-price delivery order is for the supply of 500 capsules of Ramipril 10 mg, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 10 mg ramipril capsules. The $3,693.84 order was not set aside for any specific business category. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This federal contract award, valued at $9,136.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ramipril 10 mg capsules, a medication used to treat high blood pressure and heart failure. The contract has a firm fixed-price pricing type and an ultimate completion date of November 15, 2023. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,990.40 firm fixed-price delivery order is for the supply of 4,558,265,410 capsules of 10 mg Ramipril, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of August 30, 2022 and was awarded on August 29, 2022. This award is associated with a larger...
This federal contract award (SPE2DB20D3103|SPE2DB21FP9Q9) was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554485446 - Ramipril 5 mg capsules in 500-count quantities. The contract has a ceiling value of $4,319.43 and an ultimate completion date of August 20, 2021. The award was made on a firm fixed-price basis with no set-aside designation, indicating open competition....
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX3NC
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ramipril 10 mg capsules. The contract is a Delivery Order with a Firm Fixed Price and a ceiling value of $1,007.38. It does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award for Ramipril capsules is part of Amerisourcebergen's broader role as a key supplier of pharmaceutical and medical products to various federal agencies, including the Department of Justice Federal Bureau of Investigation, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/9/25, 9:11 AM